And through all of this, over 16 million commercially insured Americans still had zero coverage for any GLP-1 medication prescribed for weight loss
Third-party testing is essential Legal status varies: clinical trials are fully legal, compounded is legal with prescription in most states, research peptides operate in a grey area FDA approval expected 2027-2028: at that point, retail pharmacy access with standard prescriptions and possible insurance coverage References Jastreboff AM, Kaplan LM, Fras JP, et al
Were here to help every step of the way. Stay tuned for more in our GLP-1 series, where well explore other important facets of these medications: from side effects and mental health impacts, to long-term strategies and the future of weight loss management
May 18, 2026 The American Society for Radiation Oncology (ASTRO) and the European Society for Radiotherapy and
Kolb, Chad Walesky, Brian J